Intent to Award Sole Source Delivery/Task Order to Anascorp Distribution LLC for Anascorp Injection, Scorpion Antivenom, IHS, Whiteriver Service Unit, Whiteriver, AZ
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Indian Health Service (IHS), Whiteriver Service Unit, intends to award a sole source contract to Anovorx Distribution LLC for Anascorp Injection (Scorpion Antivenom). This action is for the Phoenix Area, Whiteriver, AZ, and covers a period from June 1, 2026, to April 14, 2027. The government is seeking capability statements from other sources by June 6, 2026.
Scope of Work
This requirement is for the provision of Anascorp Injection [Centruroides (Scorpion) Immune F(ab')2 (Equine) Injection] on an as-needed basis. Anascorp is an equine-derived antivenom used to treat patients with clinical signs of scorpion envenomation, including loss of muscle control, respiratory distress, and vomiting. It functions by binding and neutralizing venom toxins. The product is widely utilized by Southwest Regional Indian Health Services Hospitals and Clinics in the Tucson, Albuquerque, and Phoenix Areas.
Contract & Timeline
- Type: Intent to Award Sole Source Delivery/Task Order
- Recipient: Anovorx Distribution LLC
- Authority: FSS Limited Source Justification, FAR 8.405-6(a)(1)(i)(B) and (C) (Only One Source)
- NAICS: 325412 – Pharmaceutical Preparation and Manufacturing
- Period of Performance: June 1, 2026, to April 14, 2027
- Response Due: June 6, 2026, by 4:00 PM (MST)
- Published: May 27, 2026
Submission & Evaluation
This is a notification of intent to award sole source, not a solicitation. However, responsible sources capable of providing the requested Anascorp Injection may submit a capability statement for consideration. The government's determination not to compete this acquisition is solely at its discretion. Information received will be used to determine if a competitive procurement is feasible. No proprietary, classified, confidential, or sensitive information should be included.
Additional Notes
Anovorx Distribution, LLC is identified as the only contractor offering ANASCORP under VA Contract No. 36F79718D0404. Market research, including Sources Sought Notices on GSA eBuy and SAM.gov, yielded no other responses. Pricing has been deemed fair and reasonable under Schedule contracts. Capability statements should be emailed to Donovan Conley, referencing notice number IHS1523245-WRSU-INTENT-SS.